Patient groups receiving conjugate pneumococcal vaccine in neonatal units and reasons for not recommending its use
| Indication for giving Prevenar | No of units | Reason for not recommending Prevenar | No of units |
|---|---|---|---|
| All infants <32 weeks gestation | 1 | Not sure of at risk criteria | 1 |
| All infants <30 weeks gestation | 1 | Too expensive | 2 |
| All infants with chronic lung diseases | 19 | Insufficient evidence of benefits of Prevenar in their patient group | 14 |
| Oxygen dependent infants | 4 | Currently reviewing guidelines | 3 |
| All infants who have respiratory difficulties while on the neonatal intensive care unit | 1 | Do not feel that recommendations apply to their patient group | 10 |
| Infants with congenital heart defects | 2 | Have prioritised other vaccines (BCG, hepatitis B) | 1 |
| Primary immunodeficiency | 2 | Would like more information | 1 |
| GPs in area reluctant to administer Prevenar | 3 | ||
| Previous adverse reaction in a patient | 1 |